Medix, First Half Ordinary Profit Decreases by 40%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Tue Nov 11, 2025 3:29 pm JST Earnings

331A Medix Inc. 【J-GAAP】

Earnings Report

Medix Inc. <331A> [TSE Std] announced its financial results in the afternoon session on November 11th (15:29). The ordinary profit (non-consolidated) for the cumulative second quarter of the fiscal year ending March 2026 (April to September) dropped 40.0% from the same period last year to 240 million yen. Progress toward the full-year plan of 832 million yen was 28.8%, also falling below the same period of the previous year of 42.1%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary profit for the October to March period (second half) is expected to grow 7.4% from the same period last year, reaching 592 million yen.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2025	1,937	241	240	163	20.5	28.8	Nov 11, 2025	J-GAAP
YoY	－	－	－	－	－

First Half Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Apr - Sep, 2025 Guidance	ー	ー	ー	ー	－	0	May 13, 2025	J-GAAP
Apr - Sep, 2025 Results	1,937	241	240	163	20.5	0	Nov 11, 2025	J-GAAP
Revision Rate	－	－	－	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2024	2,217	549	551	368	48.8	14	May 13, 2025	J-GAAP
Oct - Mar, 2025 Guidance	2,450	591	592	414	55.0	15	Nov 11, 2025	J-GAAP
YoY	+10.5%	+7.7%	+7.4%	+12.5%	+12.6%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2025	4,161	802	951	803	106.5	14	May 13, 2025	J-GAAP
Mar, 2026 Guidance	4,387	832	832	577	76.6	15	May 13, 2025	J-GAAP
YoY	+5.4%	+3.7%	-12.5%	-28.1%	-28.0%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2024	1,053	246	246	161	21.4	23.4	Mar 19, 2025	J-GAAP
Jan - Mar, 2025	1,164	303	305	207	27.5	26.0	May 13, 2025	J-GAAP
Apr - Jun, 2025	961	77	78	53	6.7	8.0	Aug 12, 2025	J-GAAP
Jul - Sep, 2025	976	164	162	110	13.9	16.8	Nov 11, 2025	J-GAAP
YoY	－	－	－	－	－